drugset / Trial / NCT03171324

to Assess the Effect of Early vs Routine Iron Supplementation on Iron Store and Growth in Term Infants

NCT03171324 ↗

RandomizedParallel-groupSingle-blindOther

Summary

Term infants (Small for Gestational Age and Appropriate for Gestational Age) would be randomized to receive oral iron supplementation from 6 weeks and 6 months. Growth in terms of Occipitofrontal circumference, length and weight would be monitored at 6 weeks, 6 months and 1 year of age. Hemoglobin, RBC (Red blood corpuscles) indices and ferritin would be monitored at 6 months and 1 year of age.

Timeline

Start
2017-03-01
Primary completion
2018-09-30
Completion
2018-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron Supplement Unknown 2 mg/kg Oral